1. Home
  2. DCTH vs MCFT Comparison

DCTH vs MCFT Comparison

Compare DCTH & MCFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DCTH
  • MCFT
  • Stock Information
  • Founded
  • DCTH 1988
  • MCFT 1968
  • Country
  • DCTH United States
  • MCFT United States
  • Employees
  • DCTH N/A
  • MCFT 700
  • Industry
  • DCTH Medical/Dental Instruments
  • MCFT Marine Transportation
  • Sector
  • DCTH Health Care
  • MCFT Industrials
  • Exchange
  • DCTH Nasdaq
  • MCFT Nasdaq
  • Market Cap
  • DCTH 388.3M
  • MCFT 362.2M
  • IPO Year
  • DCTH N/A
  • MCFT 2015
  • Fundamental
  • Price
  • DCTH $10.67
  • MCFT $22.69
  • Analyst Decision
  • DCTH Strong Buy
  • MCFT Hold
  • Analyst Count
  • DCTH 4
  • MCFT 6
  • Target Price
  • DCTH $24.50
  • MCFT $21.50
  • AVG Volume (30 Days)
  • DCTH 485.5K
  • MCFT 204.6K
  • Earning Date
  • DCTH 11-07-2025
  • MCFT 11-05-2025
  • Dividend Yield
  • DCTH N/A
  • MCFT N/A
  • EPS Growth
  • DCTH N/A
  • MCFT N/A
  • EPS
  • DCTH 0.06
  • MCFT 0.43
  • Revenue
  • DCTH $70,240,000.00
  • MCFT $284,203,000.00
  • Revenue This Year
  • DCTH $159.22
  • MCFT $10.53
  • Revenue Next Year
  • DCTH $41.22
  • MCFT $8.41
  • P/E Ratio
  • DCTH $193.75
  • MCFT $52.58
  • Revenue Growth
  • DCTH 491.35
  • MCFT N/A
  • 52 Week Low
  • DCTH $8.08
  • MCFT $14.39
  • 52 Week High
  • DCTH $18.23
  • MCFT $23.94
  • Technical
  • Relative Strength Index (RSI)
  • DCTH 43.30
  • MCFT 57.00
  • Support Level
  • DCTH $10.60
  • MCFT $22.31
  • Resistance Level
  • DCTH $11.38
  • MCFT $23.36
  • Average True Range (ATR)
  • DCTH 0.44
  • MCFT 1.01
  • MACD
  • DCTH 0.01
  • MCFT -0.03
  • Stochastic Oscillator
  • DCTH 5.26
  • MCFT 59.90

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

About MCFT MasterCraft Boat Holdings Inc.

MasterCraft Boat Holdings Inc designs, manufactures, and markets performance sport boats and outboard boats. The company is based in the United States and operates in three brand-specific segments. The MasterCraft segment generates the majority of the company's revenue and includes inboard boats for water skiing, wakeboarding, and wake surfing. The Pontoon segment produces pontoon boats at its Owosso, Michigan facility. Pontoon boats are used for general recreational boating. The Aviara segment produces luxury day boats at its Merritt Island, Florida facility. Aviara boats are used for general recreational boating.

Share on Social Networks: